{"Symbol": "DXCM", "AssetType": "Common Stock", "Name": "DexCom Inc", "Description": "DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.", "CIK": "1093557", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL DEVICES", "Address": "6340 SEQUENCE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121", "OfficialSite": "https://www.dexcom.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "27308937000", "EBITDA": "1163600000", "PERatio": "33.5", "PEGRatio": "0.979", "BookValue": "7.14", "DividendPerShare": "None", "DividendYield": "None", "EPS": "2.09", "RevenuePerShareTTM": "11.95", "ProfitMargin": "0.179", "OperatingMarginTTM": "0.256", "ReturnOnAssetsTTM": "0.0889", "ReturnOnEquityTTM": "0.345", "RevenueTTM": "4662000000", "GrossProfitTTM": "2801900000", "DilutedEPSTTM": "2.09", "QuarterlyEarningsGrowthYOY": "0.78", "QuarterlyRevenueGrowthYOY": "0.131", "AnalystTargetPrice": "85.46", "AnalystRatingStrongBuy": "5", "AnalystRatingBuy": "20", "AnalystRatingHold": "3", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "33.5", "ForwardPE": "28.25", "PriceToSalesRatioTTM": "5.86", "PriceToBookRatio": "9.81", "EVToRevenue": "5.65", "EVToEBITDA": "19.39", "Beta": "1.488", "52WeekHigh": "93.25", "52WeekLow": "54.11", "50DayMovingAverage": "68.88", "200DayMovingAverage": "74.19", "SharesOutstanding": "384865000", "SharesFloat": "383256000", "PercentInsiders": "0.366", "PercentInstitutions": "97.778", "DividendDate": "None", "ExDividendDate": "None"}